Harvard Bioscience Execs to Join KeyBanc Virtual Healthcare Forum
Event summary
- Harvard Bioscience CEO John Duke and Interim CFO Mark Frost to participate in KeyBanc’s Virtual Healthcare Forum on March 17, 2026.
- Fireside chat to be broadcast at 2:15pm ET on the company’s investor relations website.
- Harvard Bioscience operates in the U.S., Europe, and China, serving academic, pharmaceutical, and biotech clients globally.
The big picture
Harvard Bioscience’s participation in KeyBanc’s Virtual Healthcare Forum underscores its focus on engaging with investors and analysts during a period of heightened activity in the biotech sector. The company’s global footprint and diverse customer base position it well to capitalize on trends in pharmaceutical and therapy discovery, but it must navigate competitive pressures and economic headwinds to maintain momentum.
What we're watching
- Strategic Messaging
- How Harvard Bioscience positions itself amid increasing competition in the life sciences sector.
- Financial Performance
- Whether the company can sustain growth in its core markets amid economic uncertainties.
- Global Expansion
- The pace at which Harvard Bioscience can scale its operations in Europe and China.
Related topics